Quantum Leap Energy LLC, a wholly-owned subsidiary of ASP Isotopes Inc., signed a research agreement with the Texas A&M Engineering Experiment Station (TEES) to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6) from yellowcake uranium (U3O8). The collaboration focuses on collecting physicochemical data to improve production efficiency, reduce costs, and enhance scalability of uranium conversion technology. ASP Isotopes Inc. is an advanced materials company focused on isotope enrichment for nuclear medicine, semiconductors, and nuclear energy.

ASP Isotopes Inc. is retrospectively recasting its 2025 Annual Report on Form 10-K to present its construction services business, Skyline Builders Group Holding Limited, as discontinued operations. This accounting change follows the March 29, 2026, deconsolidation of Skyline, in which the company retained approximately 8.6% of Skyline's outstanding Class A ordinary and preferred shares. The recast financial information, including Management’s Discussion and Analysis and Financial Statements, will be incorporated into future registration statements. The company operates in the advanced materials industry, focusing on isotope enrichment for nuclear medicine, semiconductors, and nuclear energy.

ASP Isotopes Inc. and its subsidiary, Quantum Leap Energy LLC, entered into private exchange agreements to exchange approximately $109.2 million of QLE's 8.0% Convertible Promissory Notes due November 19, 2030, for approximately 23,160,682 shares of ASPI common stock. The transaction, expected to close on July 16, 2026, aims to reduce QLE's outstanding convertible notes by roughly 50%, from $219.8 million to $110.7 million, to simplify its capital structure ahead of a potential standalone public listing. The exchange represents approximately 17.8% of ASPI's common stock outstanding. ASP Isotopes Inc. is an advanced materials company specializing in isotope enrichment technologies for nuclear and industrial applications.

ASP Isotopes Inc. entered into a merger agreement with ENDRA Life Sciences Inc., Noble Africa LLC, and Renergen Limited to create a combined entity renamed Noble Africa Inc. The transaction includes a $50 million investment in Noble Africa LLC by institutional investors and the contribution of Renergen's equity to Noble Africa LLC. ENDRA may implement a reverse stock split to maintain Nasdaq compliance. ASP Isotopes Inc. operates in the specialty gas and energy sector, focusing on the production and supply of helium and liquefied natural gas resources.